Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Post-genome challenges against inflammatory bowel diseases].

Y Takei1, T Sawada, S Sameshima

  • 1Gunma Cancer Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Graft diameter does not affect re-rupture rates or clinical outcomes in double-bundle anterior cruciate ligament reconstruction.

The Knee·2025
Same author

An effective new method for the placement of an anti-adhesion barrier film using an introducer in laparoscopic surgery.

Techniques in coloproctology·2015
Same author

Differential expression of platelet-derived endothelial cell growth factor (thymidine phosphorylase) in nonpolypoid and polypoid lesions of the colon.

International journal of oncology·2011
Same author

Outcomes of hepatic artery infusion therapy for hepatic metastases from colorectal carcinoma after radiological placement of infusion catheters.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2007
Same author

Apoptotic wing degeneration and formation of an altruism-regulating glandular appendage (gemma) in the ponerine ant Diacamma sp. from Japan (Hymenoptera, Formicidae, Ponerinae).

Development genes and evolution·2005
Same author

Clinicopathologic evaluation of the trend toward histologically poor differentiation with submucosal invasion in superficial early colorectal adenocarcinomas.

Journal of gastroenterology·2000

Genome analysis advances IBD treatment by identifying genetic factors and molecular targets. This enables personalized therapies for inflammatory bowel diseases and aids in distinguishing dysplasia from inflammation.

Area of Science:

  • Genomics and Molecular Biology
  • Gastroenterology
  • Immunology

Context:

  • Inflammatory bowel diseases (IBD) management relies on current treatments like sulfadrugs, steroids, and anti-immune agents.
  • Advanced therapies for refractory IBD include leukocytapheresis, beclomethasone dipropionate, anti-TNF, and anti-LTB4 therapies.
  • Histologic identification of dysplasia is critical for surveillance in long-standing ulcerative colitis, necessitating molecular diagnosis to differentiate from regenerative changes.

Purpose:

  • To explore the impact of genome analysis on inflammatory bowel diseases (IBD) treatment.
  • To identify novel molecular targets for developing advanced IBD therapeutics.
  • To discuss the role of molecular diagnosis, including P53 immunostaining, in distinguishing dysplasia from inflammatory changes.

Summary:

Related Experiment Videos

  • Genome analysis reveals genetic factors (e.g., HLA, IL4, MUC3, IBD loci) contributing to IBD pathogenesis.
  • Dense single nucleotide polymorphism (SNP) mapping using DNA-chip technology will provide further insights into IBD-related genes.
  • P53 immunostaining is a valuable tool for molecular diagnosis in IBD surveillance.

Impact:

  • Advances in genome analysis pave the way for tailored therapies in IBD.
  • Discovery of new molecular targets is essential for developing groundbreaking IBD drugs.
  • Improved diagnostic methods enhance patient management and surveillance strategies for IBD.